Prenetics Global Limited Quick Ratio (PRE) starting from the fourth quarter 2025 to fourth quarter 2024, Financial Strength Trends, Rankings, Financial Ratios - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• Quick Ratio
• Working Capital
• LT Debt to Equity
• Debt to Equity
• Leverage Ratio
• Tangible Leverage
• Interest Coverage
• Debt Coverage
• Work. Cap. Per Revenue
Prenetics Global Limited  (NASDAQ: PRE)

Prenetics Global Limited's Quick Ratio

PRE's quarterly Quick Ratio and Cash & cash equivalent, Current Liabilities growth


Regardless of the sequential decrease in Current Liabilities, during the fourth quarter 2025, Quick Ratio deteriorated to 1.12 a new company low.

Within Laboratory Analytical Instruments industry 12 other companies have achieved higher Quick Ratio than Prenetics Global Limited in fourth quarter 2025. While Quick Ratio total ranking in the fourth quarter 2025 has deteriorated compared to the prior quarter from 1502 to 1979.

Explain Quick Ratio?
How much Cash & cash equivalents PRE´s has?
What are PRE´s Current Liabilities?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

PRE Quick Ratio (Dec 31 2025)
Q4		 0
Q3		 0
Q2		 0
Q1		 (Dec 31 2024)
Q4
Y / Y Current Liabilities Change -21.44 % -21.44 % -21.44 % -21.44 % -7.43 %
Y / Y Cash & cash equivalent Change -38.51 % -38.51 % -38.51 % -38.51 % 14.32 %
Quick Ratio MRQ 1.12 1.12 1.12 1.12 1.43
PRE's Total Ranking # 1979 # 1502 # # #
Seq. Current Liabilities Change 0 % 0 % 0 % -21.44 % 0 %
Seq. Cash & cash equivalent Change 0 % 0 % 0 % -38.51 % 0 %



Quick Ratio fourth quarter 2025 Company Ranking
Within: No.
Laboratory Analytical Instruments Industry # 13
Healthcare Sector # 658
Overall Market # 1979


Quick Ratio Statistics
High Average Low
2.56 1.57 1.12
0   (Dec 31 2025)




Financial Statements
Prenetics Global Limited's Current Liabilities $ 29 Millions Visit PRE's Balance sheet
Prenetics Global Limited's Cash & cash equivalent $ 32 Millions Visit PRE's Balance sheet
Source of PRE's Sales Visit PRE's Sales by Geography


Cumulative Prenetics Global Limited's Quick Ratio

PRE's Quick Ratio for the trailling 12 Months

PRE Quick Ratio

 (Dec 31 2025)
12 Months		 0
12 Months		 0
12 Months		 0
12 Months		 (Dec 31 2024)
12 Months
Y / Y Current Liabilities TTM Growth -21.44 % -17.73 % -14.17 % -10.73 % -7.43 %
Y / Y Cash & cash equivalent TTM Growth -38.51 % -26.58 % -13.86 % -0.26 % 14.32 %
Quick Ratio TTM 1.12 1.21 1.29 1.37 1.43
Total Ranking TTM # 4557 # 3668 # # #
Seq. Current Liabilities TTM Growth -6.39 % -6 % -5.66 % -5.36 % -1.97 %
Seq. Cash & cash equivalent TTM Growth -13.54 % -11.92 % -10.65 % -9.63 % 3.23 %

Quick ratio ranking by company, industry and sector >> Back to PRE Financial Strength Comparisons >> Go to Compare PRE Quick Ratio to its Competitors

On the trailing twelve months basis In spite of the year on year decrease in PRE's Current Liabilities to $28.71 millions, cumulative Quick Ratio to 1.12 below the PRE average Quick Ratio.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Laboratory Analytical Instruments industry 23 other companies have achieved higher Quick Ratio than Prenetics Global Limited. While Quick Ratio total ranking has deteriorated compared to the previous twelve months ending in the third quarter 2025 from 3668 to 4557.

Explain Quick Ratio?
How much Cash & cash equivalents PRE´s has?
What are PRE´s Current Liabilities?

TTM Quick Ratio Company Ranking
Within: No.
Within the Laboratory Analytical Instruments Industry # 24
Healthcare Sector # 981
Within the Market # 4557


trailing twelve months Quick Ratio Statistics
High Average Low
2.56 1.48 1.12
(Dec 31 2022)   (Dec 31 2025)




Companies with similar Quick Ratio in the quarter ending Dec 31 2025, within Laboratory Analytical Instruments Industry Quick RatioDec 31 2025 MRQ Cash & cash equivalentDec 31 2025 MRQ Current Liabilities
Bionano Genomics Inc   2.38 $ 54.561  Millions$ 22.942  Millions
Rapid Micro Biosystems Inc   2.07 $ 38.296  Millions$ 18.487  Millions
Bio rad Laboratories Inc   1.88 $ 903.200  Millions$ 480.900  Millions
Standard Biotools Inc   1.70 $ 187.575  Millions$ 110.441  Millions
Quanterix Corporation  1.58 $ 118.232  Millions$ 74.762  Millions
Prenetics Global Limited  1.12 $ 32.131  Millions$ 28.713  Millions
Lifeloc Technologies Inc   0.96 $ 0.746  Millions$ 0.778  Millions
Precipio inc   0.93 $ 2.651  Millions$ 2.851  Millions
Agilent Technologies inc   0.76 $ 1,789.000  Millions$ 2,347.000  Millions
Revvity Inc  0.69 $ 919.860  Millions$ 1,331.246  Millions
Bruker Corporation  0.51 $ 298.800  Millions$ 585.900  Millions
Waters Corporation  0.47 $ 587.831  Millions$ 1,239.499  Millions
Harvard Bioscience Inc   0.47 $ 8.614  Millions$ 18.513  Millions
Kewaunee Scientific Corporation  0.32 $ 17.164  Millions$ 53.712  Millions
Avantor Inc   0.26 $ 365.400  Millions$ 1,378.900  Millions

Date modified: 2026-07-07T12:49:11+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.